From: Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States
Olanzapine/CATIE Ratio
Cost-Neutral Ratio
Cost-Effective Ratio (ICER @ $50000)
RIS
0.64*
0.65
0.73 ($45,385)
QUE
0.44
0.88
0.89 ($60,767)
ZIP
0.57
0.75
0.80 ($43,236)
ARIP
0.77
0.80 ($44,187)